Cargando…
A narrative review of advances in treatment and survival prognosis of HER2-positive malignant lung cancers
Human epidermal growth factor receptor 2 (HER2), as a receptor tyrosine kinase of EGF receptor family, whose mutation is often associated with even if less frequency but poor prognosis and shorter survival in pulmonary malignant tumor. HER2 status include mutation, overexpression, amplification and...
Autores principales: | Wu, Ranpu, Yuan, Bingxiao, Li, Chuling, Wang, Zimu, Song, Yong, Liu, Hongbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264687/ https://www.ncbi.nlm.nih.gov/pubmed/34277062 http://dx.doi.org/10.21037/jtd-20-3265 |
Ejemplares similares
-
A narrative review of progress in diagnosis and treatment of small cell lung cancer patients with hyponatremia
por: Wu, Ranpu, et al.
Publicado: (2020) -
Comparison between immunotherapy efficacy in early non-small cell lung cancer and advanced non-small cell lung cancer: a systematic review
por: Wang, Yimin, et al.
Publicado: (2022) -
Efficacy and safety of first-line PD-1/PD-L1 inhibitor combinations for extensive-stage small-cell lung cancer: a Bayesian network meta-analysis
por: Li, Huijuan, et al.
Publicado: (2023) -
A Multicenter Retrospective Study on the Prognosis of Stage III Unresectable Mutant Non-Small Cell Lung Cancer With Tyrosine Kinase Inhibitors Therapy
por: Wu, Ranpu, et al.
Publicado: (2021) -
Metastasis-associated fibroblasts: an emerging target for metastatic cancer
por: Wang, Zimu, et al.
Publicado: (2021)